2011
DOI: 10.1016/j.jinf.2010.12.003
|View full text |Cite
|
Sign up to set email alerts
|

Aeromonas spp. clinical microbiology and disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

12
264
1
12

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 333 publications
(289 citation statements)
references
References 119 publications
12
264
1
12
Order By: Relevance
“…2,20 All of them were resistant to ampicillin and first-generation cephalosporin, however, aminoglycosides still remains good in vitro activity against these clinical isolates. Additionally, more than 83% of Aeromonas isolates were susceptible to ciprofloxacin, gentamicin, and third-generation cephalosporin.…”
Section: -16mentioning
confidence: 99%
“…2,20 All of them were resistant to ampicillin and first-generation cephalosporin, however, aminoglycosides still remains good in vitro activity against these clinical isolates. Additionally, more than 83% of Aeromonas isolates were susceptible to ciprofloxacin, gentamicin, and third-generation cephalosporin.…”
Section: -16mentioning
confidence: 99%
“…Aeromonas are Gram-negative bacteria that are autochthonous in aquatic environments and are the causative agents of human and fish infections (Figueras et al 2005, Beaz-Hidalgo et al 2010, Janda & Abbott 2010, Parker & Shaw 2011, Figueras & Beaz-Hidalgo 2015. However, in contraposition to the extensive literature implicating Aeromonas in fish diseases, few cases of Aeromonas infections have been reported in marine mammals (Cusick & Bullock 1973, Krovacek et al 1998, Thornton et al 1998, Nielsen et al 2013.…”
Section: Introductionmentioning
confidence: 99%
“…A eromonas species are Gram-negative environmental bacteria that can cause infections in both immunocompetent and immunocompromised persons (1,2) and have been isolated from a wide range of aquatic environments, including marine ecosystems, freshwater, hospital effluent, and drinking water (1,(3)(4)(5)(6). The global rise of multidrug-resistant bacteria raises concern that a ubiquitous organism, such as an Aeromonas sp., could acquire antibiotic resistance genes derived from human isolates (3,4,7,8).…”
mentioning
confidence: 99%